Method for obtaining supramolecular complex based on 3-ohypyridine derivatives and its application for correction of osteoporosis

Authors

DOI:

https://doi.org/10.18413/rrpharmacology.9.10039

Abstract

Introduction: Currently, there are no safe and ideal medicines for the prevention and treatment of oophorectomy-induced osteoporosis. The development of an effective pharmacotherapy for hypoestrogen-induced osteoporosis is an important task of pharmacology.

Materials and Methods: A new supramolecular complex (composition №1) was obtained on the basis of 3-hydroxypyridine derivatives: 2-ethyl-6-methyl-3-hydroxypyridinium 3-pyridinocarbonoate and 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyl-6-aminohexanoate in a ratio of 1:3 by topochemical synthesis. The study of the osteoprotective activity of the supramolecular complex at a dose of 50 mg/kg was performed on 60 white female rats of the Wistar line on a model of hypoestrogen-induced osteoporosis. The effectiveness of the osteoprotective activity of the complex was evaluated on the 57th day of the experiment.

Results and Discussion: The new supramolecular complex (composition №1) has osteoprotective activity, which is expressed in improving the indicators of X-ray and histomorphological samples. Oral administration of composition №1 at a dose of 50 mg/kg led to an increase in bone density to values of 2.55±0.02 g/cm3, which is 1.3 times higher than in the control group 1.92±0.01 g/cm3 (p≤0.05) and reduce bone resorption by improving cortical and trabecular bone structures.

Conclusion: The obtained data characterize the prospects of studying composition №1 for the correction and prevention of hypoestrogen-induced osteoporosis.

Graphical Abstract

Keywords:

hypoestrogen-induced osteoporosis, supramolecular complex, derivatives of 3-oxypyridine

References

Gudyrev OS, Faitelson AV, Sobolev MS, Pokrovskiy MV, Pokrovskaya TG, Korokin MV, Povetka EE, Miller ES, Soldatov VO (2019) A study of osteoprotective effect of l-arginine, l-norvaline and rosuvastatin on a model of hypoestrogen-induced osteoporosis in rats. I.P. Pavlov Russian Medical Biological Herald 27(3): 325–332. https://doi.org/10.23888/PAVLOVJ2019273325-3

Kawai M, Mödder UI, Khosla S, Rosen CJ (2011) Emerging therapeutic opportunities for skeletal restoration. Nature Reviews. Drug Discovery 10(2): 141–156. https://doi.org/10.1038/nrd3299 [PubMed] [PMC]

Kesarev OG, Danilenko LM, Pokrovskii MV, Timokhina AS, Khavanskii AV (2017) Study of dose-dependent effect of 2-ethyl-6-methyl-3 hydroxypyridine succinate on the contractile function of isolated rat heart. Research Results in Pharmacology 3 (1): 3–9. https://doi.org/10.18413/2500-235X-2017-3-1-3-9

Korokin MV, Gudyrev OS, Lebedev PR, Kuzubova EV, Radchenko AI, Koklin IS, Taran EI, Kochkarov AA (2022) Characteristics of the state of bone tissue in genetically modified mice with impaired enzymatic regulation of steroid hormone metabolism. Research Results in Pharmacology 8(4): 157–166. https://doi.org/10.3897/rrpharmacology.8.98779

Martiniakova M, Babikova M, Omelka R (2020) Pharmacological agents and natural compounds: Available treatments for osteoporosis. Journal of Physiology and Pharmacology 71(3): 556–560. https://doi.org/10.26402/jpp.2020.3.01 [PubMed]

Pakhomov DV, Blinova EV, Shimanovsky DN, Kilmyashkina MF, Kazaeva MA, Blinov DS, Nelipa MV, Nikolaev AV, Alkhatatnekh BA, Skachilova SYa, Bogoyavlenskaya TA, Kytko OV (2020) Evidence-based aspects of stimulating uncomplicated wound healing with local use of acexamic acid silver salt. Russian Journal of Operative Surgery and Clinical Anatomy 4(1): 19–25. https://doi.org/10.17116/operhirurg2020401119

Peresypkina A, Pazhinsky A, Danilenko L, Lugovskoy S, Pokrovskii M, Beskhmelnitsyna E, Solovev N, Pobeda A, Korokin M, Levkova E, Gubareva V, Korokina L, Martynova O, Soldatov V, Pokrovskii V (2020) Retinoprotective effect of 2-ethyl-3-hydroxy-6-methylpyridine nicotinate. Biology (Basel) 9(3): 45. https://doi.org/10.3390/biology9030045[PubMed] [PMC]

Trunov KS, Danilenko AP, Pokrovsky VM, Peresypkina AA, Soldatov VO, Konovalova EA, Danilenko LM, Denisuk TA, Povetkin SV, Zhernakova NI (2020) Endothelioprotective impact of 2-ethyl-3-hydroxy-6-methylpyridine nicotinate. Journal of Computational and Theoretical Nanoscience 17 (9-10): 4746–4750. https://doi.org/10.1166/jctn.2020.9372

Author Biography

Konstantin S. Trunov, Belgorod State National Research University

Research assistant of the Department of Pharmacology and Clinical Pharmacology, Belgorod State National Research University; e-mail: trunov587@gmail.com;  ORCID ID https://orcid.org/0009-0009-0658-3722.  The author carried out planning the experiments, analyzing the literature, interpreting the data and writing the article.

Downloads

Published

30-07-2023

How to Cite

Trunov KS (2023) Method for obtaining supramolecular complex based on 3-ohypyridine derivatives and its application for correction of osteoporosis. Research Results in Pharmacology 9(3): 21–25. https://doi.org/10.18413/rrpharmacology.9.10039

Issue

Vol. 9 No. 3 (2023)

Section

Short Communication

License

Copyright (c) 2023 Research Results in Pharmacology

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)